Sanofi-Aventis SA (SNY) said Tuesday that Jiri Michal, the chief executive of Zentiva NV, the Czech-based generics unit of the French-Swiss pharmaceutical company, is stepping down as of July 1 after 36 years at the company.
![](https://praguemonitor.com/wp-content/uploads/2023/11/f-meyqwiaai6ru-3-300x300.jpg)
Sanofi-Aventis SA (SNY) said Tuesday that Jiri Michal, the chief executive of Zentiva NV, the Czech-based generics unit of the French-Swiss pharmaceutical company, is stepping down as of July 1 after 36 years at the company.
most viewed
© 2023 The Prague Monitor